CytoVale is a biotechnology research company that uses early detection strategies for auto-immune diseases. The company has a mission of using diagnostic interventions to create faster, easier-to-implement medical treatment for patients. Other features of CytoVale are microfluidics and biophysical machine learning. CytoVale was founded by Ajay Shah and Dino Di Carlo in 2013 and is headquartered in San Francisco, CA.

Register for Details

For more details on financing and valuation for CytoVale, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about CytoVale

Forge green plus iconForge green minus icon

What is CytoVale's IPO price?

The IPO price for CytoVale will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in CytoVale?

CytoVale is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell CytoVale shares pre-IPO?

If you own CytoVale pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is CytoVale a publicly traded company?

CytoVale is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

When was CytoVale founded?

CytoVale was founded in 2013.

Who are CytoVale's major investors?

Norwest Venture Partners
Western Technology Investment
National Science Foundation
Grids Capital
Baidu Ventures
Google for Startups Accelerator
National Institutes of Health
Sands Capital
Dolby Family Ventures
Breakout Ventures
U.S. Department of Health and Human Services
Global Health Investment Fund
Kayyak Ventures
Pathway Bioventures
Biomedical Advanced Research and Development Authority
Blackhorn Ventures
Pactolus Ventures
Farmore Capital Group
Breakout Labs
Updated on: May 21, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.